Hypertension Channel
Topics
Medications
Quicklinks
Related Channels

Specific Safety Concerns With Eprosartan

Specific Eprosartan Precautions and Warnings

Some warnings and precautions to be aware of prior to taking this medication include the following:
 
  • Eprosartan can cause a potentially dangerous swelling below the surface of the skin, called angioedema, especially within the first month of treatment. Stop taking eprosartan and seek immediate medical care if you develop any symptoms of angioedema, such as difficulty breathing or swelling of the face, eyes, lips, tongue, hands, or feet.
 
  • You may experience dizziness or lightheadedness when you first start taking eprosartan as your blood pressure begins to lower. If you find yourself fainting, stop taking this drug and contact your healthcare provider as soon as possible.
 
  • Sweating, dehydration (which could occur if you do not drink enough fluids), vomiting, and diarrhea could cause your blood pressure to lower to unsafe levels while taking eprosartan. Stay hydrated by drinking plenty of fluids, and let your healthcare provider know if you develop these symptoms. Additionally, any of these conditions, as well as taking a diuretic ("water pill"), may increase the risk of kidney failure due to this medication.
 
  • You should not use potassium supplements or salt substitutes that contain potassium without first checking with your healthcare provider. Eprosartan may cause an increase in blood potassium levels (hyperkalemia), and taking products that contain potassium may further increase the level of potassium in your blood. People who have kidney disease or diabetes also have an increased risk for hyperkalemia from eprosartan.
 
  • If you are having any major surgery, make sure your healthcare provider knows you are taking eprosartan.
 
  • This medication may cause a decrease in kidney function, especially in people who are elderly, have kidney disease, have severe congestive heart failure (CHF), or are taking nonsteroidal anti-inflammatory drugs (NSAIDs). Your healthcare provider may choose to monitor your kidney function with a blood test while you are taking eprosartan. Contact your healthcare provider if you notice a decrease in urination or swelling in your hands, legs, ankles, or feet, which can be signs of kidney problems.
 
 
  • Eprosartan is a pregnancy Category D medication. This means that it may cause harm to an unborn child (see Teveten and Pregnancy).
 
  • It is not known whether eprosartan passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to taking this medication (see Teveten and Breastfeeding).
 
Life After a Stent: 5 Realistic Ways to Take Charge of Your Health

Eprosartan Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.